These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34195281)

  • 1. Downregulation of snoRNA SNORA52 and Its Clinical Significance in Hepatocellular Carcinoma.
    Ding Y; Sun Z; Zhang S; Li Y; Han X; Xu Q; Zhou L; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
    Biomed Res Int; 2021; 2021():7020637. PubMed ID: 34195281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma.
    Ding Y; Sun Z; Zhang S; Xu Q; Zhou L; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32697317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
    Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
    World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of snoRNA SNORA71A as a Novel Biomarker in Prognosis of Hepatocellular Carcinoma.
    Ding Y; Sun Z; Zhang S; Zhou L; Xu Q; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
    Dis Markers; 2020; 2020():8879944. PubMed ID: 33062075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Guo X; Xiong L; Yu L; Li R; Wang Z; Ren B; Dong J; Li B; Wang D
    Diagn Pathol; 2014 Sep; 9():175. PubMed ID: 25230759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
    Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
    World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated calcium-binding tyrosine phosphorylation-regulated protein-a/b regulates cell proliferation and apoptosis and predicts poor prognosis in hepatocellular carcinoma.
    Yu XN; Guo HY; Liu TT; Zhang GC; Zhu HR; Shi X; Song GQ; Jiang XM; Huang XX; Weng SQ; Dong L; Shen XZ; Huang YQ; Zhu JM
    J Cell Biochem; 2020 Apr; 121(4):2938-2949. PubMed ID: 31692072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
    Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy.
    Xieraili M; Yasen M; Mogushi K; Obulhasim G; Mayinuer A; Aihara A; Tanaka S; Mizushima H; Tanaka H; Arii S
    Cancer Sci; 2012 Aug; 103(8):1493-501. PubMed ID: 22530999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of MicroRNA-1 is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Wang X; Huang Y; Zhuang H; Qian Y; Zhao Q; Yang L; Gu H; Chen J; Guo R; Liu Y
    Clin Lab; 2015; 61(9):1331-6. PubMed ID: 26554254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
    Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C
    Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TINCR expression is associated with unfavorable prognosis in patients with hepatocellular carcinoma.
    Tian F; Xu J; Xue F; Guan E; Xu X
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28546230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis.
    Liu B; Zhang J; Huang C; Liu H
    PLoS One; 2012; 7(8):e43147. PubMed ID: 22912812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
    Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
    Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
    Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
    Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
    PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma.
    Li M; Luo RZ; Chen JW; Cao Y; Lu JB; He JH; Wu QL; Cai MY
    J Transl Med; 2011 Jan; 9():5. PubMed ID: 21205329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.